Z-1440-2017 Class II Terminated

Recalled by Becton Dickinson & Company — Franklin Lakes, NJ

FDA device recall Z-1440-2017 was initiated by Becton Dickinson & Company on Dec 20, 2016 and is designated Class II. Reason for recall: BD is initiating a Product Advisory for the Eclipse Hypodermic Needle because of safety complaints covering disengagement and needlestick injuries. The recall status is terminated (terminated Apr 20, 2018). Affected quantity: 263 mm units.

Recall details

Product Type
Devices
Report Date
Mar 22, 2017
Initiation Date
Dec 20, 2016
Termination Date
Apr 20, 2018
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
263 mm units

Product description

Eclipse Hypodermic Needle

Reason for recall

BD is initiating a Product Advisory for the Eclipse Hypodermic Needle because of safety complaints covering disengagement and needlestick injuries.

Distribution pattern

US Nationwide

Code information

N/A

Source

Dataset
openFDA device recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for Z-1440-2017
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for Z-1440-2017. Report a data issue: hello@regdatalab.com.